An $8.5 billion sale is now official, closing a chapter on a controversial business arm for this Houston company.
Newspoint on MSN
Small cell lung cancer: New hope for lung cancer patients, an AI tool will predict the effect of treatment in advance
Lung cancer survival rate: Small-cell lung cancer is one of the most dangerous cancers worldwide. Let us tell you what has been discovered about it, which has raised new hopes. Can AI predict cancer ...
Olvi-Vec shows potential in treating advanced lung cancer, demonstrating tumor shrinkage and disease control in patients unresponsive to platinum-based treatments. The investigational therapy is an ...
About 40% of people with non-small cell lung cancer (NSCLC)—a type of cancer that begins in the tissues of your lungs—have metastatic disease at the time of their diagnosis. Metastatic NSCLC refers to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results